JMS Co.,Ltd.

Equities

7702

JP3386050003

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-02 am EDT			5-day change	1st Jan Change
534 ^JPY	+0.95%		+1.71%	+6.16%

2023	JMS Co.,Ltd. Announces Dividend for the Second Quarter ended September 2023 Payable on December 8, 2023; Provides Guidance for the Year End for the Year March 31, 2024	CI
2023	JMS Co.,Ltd. Provides Earnings Guidance for the Year Ending March 31, 2024	CI

JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023

February 07, 2023 at 01:00 am EST

JMS Co.,Ltd. provided consolidated earnings guidance for the year ending March 31, 2023. For the year, the company expects consolidated net sales of JPY 62,000 million, operating profit of JPY 400 million, profit attributable to owners of parent of JPY 200 million and basic earnings per share of JPY 8.18.

Latest news about JMS Co.,Ltd.

JMS Co.,Ltd. Announces Dividend for the Second Quarter ended September 2023 Payable on December 8, 2023; Provides Guidance for the Year End for the Year March 31, 2024	Nov. 07	CI
JMS Co.,Ltd. Provides Earnings Guidance for the Year Ending March 31, 2024	Nov. 07	CI
JMS Co.,Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI
JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 2023 and Full Year Ending March 2024	23-05-12	CI
JMS Co.,Ltd. Announces Dividend for the Year Ended March 31, 2023, Payable on June 28, 2023; Provides Dividend Guidance for the Second Quarter End and Fiscal Year Ending March 31, 2024	23-05-12	CI
JMS Co.,Ltd. Provides Year-End Dividend Guidance for the Year Ending March 31, 2023	23-02-07	CI
JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023	23-02-07	CI
JMS Co.,Ltd.(TSE:7702) dropped from S&P Global BMI Index	22-09-19	CI
JMS Co.,Ltd. agreed to acquire myBeat Home ECG business of Union Tool Co. from Union Tool Co..	22-06-29	CI
Fresenius Medical Care Partners with JMS Co. Ltd. to Advance Home Dialysis Treatment in Japan	21-09-17	CI
JMS Co.,Ltd. agreed to acquire blood purification business from Japan Lifeline Co., Ltd..	21-02-25	CI
JMS Co.,Ltd.(TSE:7702) added to S&P Global BMI Index	20-09-21	CI
Jms Co.,Ltd. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2019; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2020	20-02-05	CI
JMS Co.,Ltd. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2019; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2020; Announces Dividend for the Second Quarter Ended September 30, 2019 , Payable on December 10, 2019; Provides Year-End Dividend Guidance for the Year Ending March 31, 2020	19-11-10	CI
Jms Co.,Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Earnings Guidance for the Half Year and Full Year for the Fiscal Year Ending March 31, 2020; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal Year Ending March 31, 2020	19-08-06	CI
JMS Co.,Ltd. Announces Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Earnings Guidance for the Six Months Ending September 30, 2018 and Full Year Ending March 31, 2019; Announces Dividend for the Year Ended March 31, 2018, Payable on June 22, 2018; Provides Dividend Guidance for the Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2019	18-05-17	CI
JMS Co.,Ltd, Thippayabadin Company Limited, and B&J Logistic Co., Ltd Establishes Joint Venture Company in Thailand	18-03-06	CI
JMS Co.,Ltd. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2018	18-02-07	CI
Jms Co.,Ltd. Reports Unaudited Consolidated Earnings Results for the Second Quarter Ended September 30, 2017; Announces Consolidated Earnings Guidance for the Year Ending March 31, 2018; Declares Dividend for the Second Quarter Ended September 30, 2017, Payable on December 8, 2017; Provides Year-End Dividend Guidance for the Year Ending March 31, 2018	17-11-08	CI
JMS Co.,Ltd. announces an Equity Buyback for 197 shares.	17-10-18	CI
JMS Co.,Ltd.'s Equity Buyback announced on October 18, 2017 has expired.	17-10-17	CI
JMS Co.,Ltd. authorizes a Buyback Plan.	17-10-17	CI
JMS Co., Ltd. Reports Consolidated Earnings Results for the Year Ended March 31, 2017; Provides Earnings Guidance for the Six Months Ending September 30, 2017 and Year Ending March 31, 2018	17-05-11	CI
JMS Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended Dec. 31, 2016; Reaffirms Earnings Guidance for the Fiscal Year Ending March 31, 2017	17-02-09	CI
JMS Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2017	16-11-10	CI

Chart JMS Co.,Ltd.

Duration

Period

More charts

Company Profile

JMS CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of medical equipment and drugs. The Company operates through five geographical segments including Japan, Singapore, China, Philippines and Germany. The Company is engaged in the manufacture and sale of infusion and nutrition products, dialysis products, surgery products, blood and cell products and other products. The Companyâs main products include infusion & transfusion set, syringe pump, surgical gown, dialysis kit, peritoneal dialysate, microcatheter, blood bag, among others. The Company is also involved in the provision of maintenance service and other related services.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-13 - Q4 2023 Earnings Release

More about the company

	1st Jan change	Capi.
JMS CO.,LTD.	+6.16%	85.5M
ABBOTT LABORATORIES	-3.79%	184B
MEDTRONIC PLC	-0.84%	108B
BECTON, DICKINSON AND COMPANY	-3.75%	67.82B
DEXCOM, INC.	+3.45%	51.05B
CENCORA, INC.	+9.04%	44.67B
HOYA CORPORATION	+3.40%	41.78B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.21%	26.78B
WEST PHARMACEUTICAL SERVICES, INC.	+3.66%	26.59B
TERUMO CORPORATION	+15.23%	25.86B

Other Medical Equipment, Supplies & Distribution

JMS Co.,Ltd.

Equities

7702

JP3386050003

Medical Equipment, Supplies & Distribution

JMS Co.,Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023

Latest news about JMS Co.,Ltd.

Chart JMS Co.,Ltd.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution